Literature DB >> 6473634

Tardive dyskinesia--animal models.

D E Casey.   

Abstract

Entities:  

Mesh：

Year:  1984        PMID： 6473634

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  7 in total

1.  Effect of extended depot fluphenazine treatment and withdrawal on social and other behaviors of Cebus apella monkeys.

Authors:  K Lifshitz; R T O'Keeffe; K L Lee; G S Linn; D Mase; J Avery; E S Lo; T B Cooper
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.

Authors:  H Lublin; J Gerlach; F Mørkeberg
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

3.  Effects of chronic haloperidol on stress-induced oral behaviour in rats.

Authors:  J N Nobrega; L M Dixon; L R Troncone; H T Barros
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Involvement of noradrenergic system in a remarkably rapid tongue clonus produced by acute hypnotic doses of ethanol in Fischer F344 rats.

Authors:  M K Menon; R L Lloyd
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities.

Authors:  S Mithani; S Atmadja; K G Baimbridge; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.

Authors:  R E See; E D Levin; G D Ellison
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.

Authors:  J L Neisewander; E Castañeda; D A Davis
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.